RESEARCH TRIANGLE PARK, N.C., April 26 /PRNewswire-FirstCall/ -- Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) will release its first quarter 2010 financial results on April 28, 2010, after the stock market closes and will host a conference call at 8:30 a.m. Eastern Time on April 29, 2010.
Investors and analysts may participate via phone by calling 1-888-713-4205 (domestic) or 1-617-213-4862 (international), pass code number 21563385. To ensure timely access, please dial into the call approximately 10 minutes before it is scheduled to begin. The listen-only webcast will also be available through the investor relations section of http://www.talecris.com.
Participants may pre-register for the conference call at: https://www.theconferencingservice.com/prereg/key.process?key=PPMXLQM7G. Pre-registrants will be issued a PIN number to use when dialing into the live call, which will provide quick access to the conference by bypassing the operator upon connection.
A replay of the conference call will be available beginning approximately two hours after the call concludes and will remain accessible until May 6, 2010, by dialing 1-888-286-8010 (domestic) or 1-617-801-6888 (international), pass code number 40214869. The webcast of the conference call will be archived on the investor relations section of http://www.talecris.com.
About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.
Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas, including immunology, pulmonology, neurology and hemostasis. For more information, please visit: www.talecris.com.
|SOURCE Talecris Biotherapeutics, Inc.|
Copyright©2010 PR Newswire.
All rights reserved